Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMWP6OZ)

Drug Name

N-(1,3,4-thiadiazol-2-yl)benzamide Drug Info

Synonyms

N-(1,3,4-Thiadiazol-2-yl)benzamide; RWOUBULBQYRRNL-UHFFFAOYSA-N; N-1,3,4-thiadiazol-2-yl-benzamide; 26861-95-0; BAS 03031913; AC1LC4SO; TimTec1_007967; CHEMBL390098; SCHEMBL3379803; CTK0I5904; DTXSID40341040; MolPort-001-017-069; HMS1556K03; ZINC892651; STK158583; AKOS000646792; MCULE-9389828263; N-[1,3,4]Thiadiazol-2-yl-benzamide; IDI1_033621; Benzamide, N-1,3,4-thiadiazol-2-yl-; N-([1,3,4]thiadiazol-2-yl)-benzamide; N~1~-(1,3,4-thiadiazol-2-yl)benzamide; ST50015221; phenyl-N-(1,3,4-thiadiazol-2-yl)carboxamide; SR-01000365353

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 569548
CAS Number: CAS 26861-95-0
TTD Drug ID: DMWP6OZ

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
LOX-5 messenger RNA (ALOX5 mRNA)	TTSJ6Q4	LOX5_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
LOX-5 messenger RNA (ALOX5 mRNA)	DTT	ALOX5	4.966	5.133	5.358	6.128

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
LOX-5 messenger RNA (ALOX5 mRNA)	DTT	ALOX5	9.43E-03	0.14	0.28

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6.